La información más actual para el médico de familia
Prensa Tema Resúmenes Revistas Internet Usuarios registrados | Quiénes somos
Más actualidad
Buscador
 
Búsqueda avanzada

Revistas

(Semana 28/07/2014 - 03/08/2014)

BMJ-British Medical Journal. Vol. 349. Núm. 7969

Originales

Wang X, Ouyang Y, Liu J, Zhu M, Zhao G, Bao W, Hu FBFruit and vegetable consumption and mortality from all causes, cardiovascular disease, and cancer: systematic review and dose-response meta-analysis of prospective cohort studies. Págs. g4490 TC PDF 

Crider KS, Devine O, Hao L, Dowling NF, Li S, Molloy AM et alPopulation red blood cell folate concentrations for prevention of neural tube defects: bayesian model. Págs. g4554 TC PDF 

Editoriales

Scammell BECalcaneal fractures. Págs. g4779 TC (s) PDF (s) 

Stanley M, O’Mahony C, Barton SHPV vaccination. Págs. g4783 TC (s) PDF (s) 

Clarke R, Bennett DFolate and prevention of neural tube defects. Págs. g4810 TC (s) PDF (s) 

Shelley JSpacing babies. Págs. g4717 TC (s) PDF (s) 

Revisiones

Sattar N, Forrest E, Preiss DNon-alcoholic fatty liver disease. Págs. g4596 TC (s) PDF (s) 

Práctica clínica

Steele C, Conlon N, Edgar JDDiagnosis of immediate food allergy. Págs. g3695 TC (s) PDF (s) 

Guías de práctica clínica

Carville S, Wonderling D, Stevens P on behalf of the Guideline Development GroupEarly identification and management of chronic kidney disease in adults: summary of updated NICE guidance. Págs. g4507 TC (s) PDF (s) 

New England Journal of Medicine. Vol. 371. Núm. 5

Editoriales

Greenwood BTreatment of Malaria — A Continuing Challenge. Págs. 474-475 TC PDF 

Revisiones

Brouwer MC, Tunkel AR, I GM, van de Beek DBrain Abscess. Págs. 447-456 TC (s) PDF (s) 

Isbister GK, Bawaskar HSScorpion Envenomation. Págs. 457-463 TC (s) PDF (s) 

Perspectiva

Richter K, Levy SBig Marijuana — Lessons from Big Tobacco. Págs. 399-401 TC (s) PDF (s) 

Gut. Vol. 63. Núm. 8

Originales

Singh S, Garg SK, Singh PP, Iyer PG, El-Serag HBAcid-suppressive medications and risk of oesophageal adenocarcinoma in patients with Barrett's oesophagus: a systematic review and meta-analysis. Págs. 1229-1237 R TC (s) PDF (s) 

Kim G, Lim Y, An J, Lee D, Shim JH, Kim KM et alHBsAg seroclearance after nucleoside analogue therapy in patients with chronic hepatitis B: clinical outcomes and durability. Págs. 1325-1332 R TC (s) PDF (s) 

Guías de práctica clínica

Ludvigsson JF, Bai JC, Biagi F, Card TR, Ciacci C, Ciclitira PJ et alDiagnosis and management of adult coeliac disease: guidelines from the British Society of Gastroenterology. Págs. 1210-1228 R TC PDF 

Circulation. Vol. 130. Núm. 5

Originales

Leong DP, Smyth A, Teo KK, McKee M, Rangarajan S, Pais P, Liu L et al on behalf of the INTERHEART InvestigatorsPatterns of Alcohol Consumption and Myocardial Infarction Risk: Observations From 52 Countries in the INTERHEART Case–Control Study. Págs. 390-398 R TC (s) PDF (s) 

Editoriales

Kiechl S, Willeit JComplex Association Between Alcohol Consumption and Myocardial Infarction: Always Good for a New Paradox. Págs. 383-386 TC (s) PDF (s) 

Shantsila E, Lip GYThrombotic Complications in Heart Failure: An Underappreciated Challenge. Págs. 387-389 TC (s) PDF (s) 

Revisiones

Meinel FG, Nance JW, Harris BS, Cecco CN, Costello P, Schoepf UJRadiation Risks From Cardiovascular Imaging Tests. Págs. 442-445 TC PDF 

Páginas para los pacientes

Mirabel M, Narayanan K, Jouven X, Marijon EPrevention of Acute Rheumatic Fever and Rheumatic Heart Disease. Págs. e35-e37 TC PDF 

Thorax. Vol. 69. Núm. 8

Originales

Donaldson GCExacerbations in non-COPD patients: recognition?. Págs. 689-690 TC (s) PDF (s) 

Pickering CAHumidifiers: the use of biocides and lung disease. Págs. 692-693 TC (s) PDF (s) 

Tan WC, Bourbeau J, Hernandez P, Chapman KR, Cowie R, FitzGerald JMExacerbation-like respiratory symptoms in individuals without chronic obstructive pulmonary disease: results from a population-based study. Págs. 709-717 R TC PDF 

Williams MC, Murchison JT, Edwards LD, Agustí A, Bakke P, Calverley PM for the ECLIPSE InvestigatorsCoronary artery calcification is increased in patients with COPD and associated with increased morbidity and mortality. Págs. 718-723 R TC (s) PDF (s) 

European Heart Journal. Vol. 349. Núm. 7968

Originales

Coppens M, Synhorst D, Eikelboom JW, Yusuf S, Shestakovska O, Connolly SJEfficacy and safety of apixaban compared with aspirin in patients who previously tried but failed treatment with vitamin K antagonists: results from the AVERROES tria. Págs. 1856-1863 R TC (s) PDF (s) 

Halvorsen S, Atar D, Yang H, De Caterina R, Erol C, Garcia D et alEfficacy and safety of apixaban compared with warfarin according to age for stroke prevention in atrial fibrillation: observations from the ARISTOTLE trial. Págs. 1864-1872 R TC PDF 

Piccini JP, Garg J, Patel MR, Lokhnygina Y, Goodman SG, Becker RC et al on behalf of the ROCKET AF trialManagement of major bleeding events in patients treated with rivaroxaban vs. warfarin: results from the ROCKET AF trial. Págs. 1873-1880 R TC PDF 

Azoulay L, Dell'Aniello S, Simon TA, Renoux C, Suissa SInitiation of warfarin in patients with atrial fibrillation: early effects on ischaemic strokes. Págs. 1881-1887 R TC (s) PDF (s) 

Beyer-Westendorf J, Gelbricht V, Förster K, Ebertz F, Köhler C, Werth S et alPeri-interventional management of novel oral anticoagulants in daily care: results from the prospective Dresden NOAC registry. Págs. 1888-1896 R TC PDF 

Dorian P, Kongnakorn T, Phatak H, Rublee DA, Kuznik A, Lanitis T et alCost-effectiveness of apixaban vs. current standard of care for stroke prevention in patients with atrial fibrillation. Págs. 1897-1906 R TC PDF 

Editoriales

Vanassche T, Lauw MN, Connolly SJ, Eikelboom JWHeparin bridging in peri-procedural management of new oral anticoagulant: a bridge too far?. Págs. 1831-1833 TC (s) PDF (s) 

Diener HC, Granger CB, Patel MRIs there a period of liability with initiation of warfarin in patients with atrial fibrillation?. Págs. 1834-1835 TC (s) PDF (s) 

Revisiones

Fontana P, Goldhaber SZ, Bounameaux HDirect oral anticoagulants in the treatment and long-term prevention of venous thrombo-embolism. Págs. 1836-1843 R TC (s) PDF (s) 

Lip GY, Agnelli GEdoxaban: a focused review of its clinical pharmacology. Págs. 1844-1855 R TC (s) PDF (s) 

Claves

R Resumen    TC Texto completo    PDF Portable Document File (Adobe Reader)    RC Resumen comentado    (s) Sólo suscriptores   

Contacto con AP al día: apaldia@apaldia.com
© MEDIGRAF 2014.
Esta web se dirige exclusivamente a los profesionales del sector médico.